David Happel

SGMT

David Happel serves as director, officer: President & CEO at Sagimet Biosciences Inc. (SGMT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$71.7K

Total Sells

2 trades

$663.0K

Net Position

Net Seller

$591.3K

Companies Traded

SGMT

Active Period

Nov 2023 – Feb 2026

5 total trades

Most Recent

Sell SGMT

Feb 12, 2026 · $64.9K

David Happel's Insider Trading at Sagimet Biosciences Inc. (SGMT)

Buys

3 · $71.7K

Sells

2 · $663.0K

Total Shares Bought

14,290

Total Shares Sold

77,579

SGMT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 12, 2026	Sell	12,101	$5.36	$64.9K	677,621
Jul 23, 2025	Sell	65,478	$9.13	$598.1K	689,722
Mar 28, 2024	Buy	12,100	$5.27	$63.7K	639,200
Dec 8, 2023	Buy	1,600	$4.10	$6.6K	627,100
Nov 20, 2023	Buy	590	$2.35	$1.4K	590